UPDATE 1-Allergan ordered to show 'business strategy' docs: Frankel

NEW YORK (Reuters) - (Reuters) - Allergan's attempt to ward off a precedent-setting joint bid by the Canadian pharmaceutical company Valeant and the hedge fund Pershing Square continues to remake the rulebook for hostile takeovers. On Monday, U.S. District Judge David Carter of Santa Ana, Calif., ordered Allergan to turn over to lawyers for Valeant and Pershing the complete records of recent board meetings and other strategic documents despite Allergan's arguments that the documents would exp
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.